{"count": 18, "results": [{"_id": "37133558", "pmid": 37133558, "pmcid": "PMC10172247", "title": "The comparative effectiveness of metformin and risperidone in a rat model of valproic acid-induced autism, Potential role for enhanced autophagy", "journal": "Psychopharmacology (Berl)", "authors": ["Atia AA", "Ashour RH", "Zaki MM", "Rahman KM", "Ramadan NM"], "date": "2023-06-01T00:00:00Z", "doi": "10.1007/s00213-023-06371-1", "meta_date_publication": "2023 Jun", "meta_volume": "240", "meta_issue": "6", "meta_pages": "1313-1332", "score": 50266.79, "text_hl": "...Is @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@'s ability to improve @<m>DISEASE_Autism_Spectrum_Disorder</m> @DISEASE_MESH:D000067877 @@@ASD@@@ clinical phenotype driven by its autophagy-enhancing properties? ", "citations": {"NLM": "Atia AA, Ashour RH, Zaki MM, Rahman KM, Ramadan NM. The comparative effectiveness of metformin and risperidone in a rat model of valproic acid-induced autism, Potential role for enhanced autophagy Psychopharmacology (Berl). 2023 Jun;240(6):1313-1332. PMID: 37133558", "BibTeX": "@article{37133558, title={The comparative effectiveness of metformin and risperidone in a rat model of valproic acid-induced autism, Potential role for enhanced autophagy}, author={Atia AA and Ashour RH and Zaki MM and Rahman KM and Ramadan NM}, journal={Psychopharmacology (Berl)}, volume={240}, number={6}, pages={1313-1332}}"}}, {"_id": "35029811", "pmid": 35029811, "pmcid": "PMC9130393", "title": "An Update on Psychopharmacological Treatment of Autism Spectrum Disorder", "journal": "Neurotherapeutics", "authors": ["Aishworiya R", "Valica T", "Hagerman R", "Restrepo B"], "date": "2022-01-01T00:00:00Z", "doi": "10.1007/s13311-022-01183-1", "meta_date_publication": "2022 Jan", "meta_volume": "19", "meta_issue": "1", "meta_pages": "248-262", "score": 50259.426, "text_hl": "Such polypharmacy will be more common as specific treatments for dysfunctional pathways are utilized which go hand in hand with other treatments for common comorbidities of @<m>DISEASE_Autism_Spectrum_Disorder</m> @DISEASE_MESH:D000067877 @@@ASD@@@. An example is @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ which can downregulate the @GENE_MTOR @GENE_2475 @@@mTOR@@@ pathway, and this treatment works well with @CHEMICAL_Amphetamines @CHEMICAL_MESH:D000662 @@@stimulants@@@ for @DISEASE_Attention_Deficit_Disorder_with_Hyperactivity @DISEASE_MESH:D001289 @@@ADHD@@@ and also Selective Serotonin Reuptake Inhibitors (SSRIs) for @DISEASE_Anxiety @DISEASE_MESH:D001007 @@@anxiety@@@.", "citations": {"NLM": "Aishworiya R, Valica T, Hagerman R, Restrepo B. An Update on Psychopharmacological Treatment of Autism Spectrum Disorder Neurotherapeutics. 2022 Jan;19(1):248-262. PMID: 35029811", "BibTeX": "@article{35029811, title={An Update on Psychopharmacological Treatment of Autism Spectrum Disorder}, author={Aishworiya R and Valica T and Hagerman R and Restrepo B}, journal={Neurotherapeutics}, volume={19}, number={1}, pages={248-262}}"}}, {"_id": "35222739", "pmid": 35222739, "pmcid": "PMC8872653", "title": "Metformin Alleviates Autistic-Like Behaviors Elicited by High-Fat Diet Consumption and Modulates the Crosstalk Between Serotonin and Gut Microbiota in Mice", "journal": "Behav Neurol", "authors": ["Deng W", "Ke H", "Wang S", "Li Z", "Li S", "Lv P", "Li F", "Chen Y"], "date": "2022-02-17T00:00:00Z", "doi": "10.1155/2022/6711160", "meta_date_publication": "2022", "meta_volume": "2022", "meta_issue": "", "meta_pages": "6711160", "score": 50259.22, "text_hl": "At present, no drugs are available to treat the core symptoms of @<m>DISEASE_Autism_Spectrum_Disorder</m> @DISEASE_MESH:D000067877 @@@ASD@@@. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@) is the most commonly used drug for treating @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@, but it has been shown to have many additional physiological effects. ", "citations": {"NLM": "Deng W, Ke H, Wang S, Li Z, Li S, Lv P, Li F, Chen Y. Metformin Alleviates Autistic-Like Behaviors Elicited by High-Fat Diet Consumption and Modulates the Crosstalk Between Serotonin and Gut Microbiota in Mice Behav Neurol. 2022;2022():6711160. PMID: 35222739", "BibTeX": "@article{35222739, title={Metformin Alleviates Autistic-Like Behaviors Elicited by High-Fat Diet Consumption and Modulates the Crosstalk Between Serotonin and Gut Microbiota in Mice}, author={Deng W and Ke H and Wang S and Li Z and Li S and Lv P and Li F and Chen Y}, journal={Behav Neurol}, volume={2022}, pages={6711160}}"}}, {"_id": "38176793", "pmid": 38176793, "title": "An Update on Psychopharmacological Treatment of Autism Spectrum Disorder.", "journal": "Neurotherapeutics", "authors": ["Aishworiya R", "Valica T", "Hagerman R", "Restrepo B"], "date": "2022-01-01T00:00:00Z", "doi": "10.1007/s13311-022-01183-1", "meta_date_publication": "2022 Jan", "meta_volume": "19", "meta_issue": "1", "meta_pages": "248-262", "score": 50255.773, "text_hl": "An Update on Psychopharmacological Treatment of @<m>DISEASE_Autism_Spectrum_Disorder</m> @DISEASE_MESH:D000067877 @@@Autism Spectrum Disorder@@@.", "citations": {"NLM": "Aishworiya R, Valica T, Hagerman R, Restrepo B. An Update on Psychopharmacological Treatment of Autism Spectrum Disorder. Neurotherapeutics. 2022 Jan;19(1):248-262. PMID: 38176793", "BibTeX": "@article{38176793, title={An Update on Psychopharmacological Treatment of Autism Spectrum Disorder.}, author={Aishworiya R and Valica T and Hagerman R and Restrepo B}, journal={Neurotherapeutics}, volume={19}, number={1}, pages={248-262}}"}}, {"_id": "34502168", "pmid": 34502168, "pmcid": "PMC8431328", "title": "Influence of the Aryl Hydrocarbon Receptor Activating Environmental Pollutants on Autism Spectrum Disorder", "journal": "Int J Mol Sci", "authors": ["Dhulkifle H", "Agouni A", "Zeidan A", "Al-Kuwari MS", "Parray A", "Tolefat M", "Korashy HM"], "date": "2021-08-26T00:00:00Z", "doi": "10.3390/ijms22179258", "meta_date_publication": "2021 Aug 26", "meta_volume": "22", "meta_issue": "17", "meta_pages": "", "score": 50255.176, "text_hl": "In addition, the review explores possible new @GENE_AHR @GENE_196 @@@AhR@@@-mediated mechanisms of several drugs used for treatment of @<m>DISEASE_Autism_Spectrum_Disorder</m> @DISEASE_MESH:D000067877 @@@ASD@@@, such as @CHEMICAL_sulforaphane @CHEMICAL_MESH:C016766 @@@sulforaphane@@@, @CHEMICAL_Resveratrol @CHEMICAL_MESH:D000077185 @@@resveratrol@@@, @CHEMICAL_Haloperidol @CHEMICAL_MESH:D006220 @@@haloperidol@@@, and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@.", "citations": {"NLM": "Dhulkifle H, Agouni A, Zeidan A, Al-Kuwari MS, Parray A, Tolefat M, Korashy HM. Influence of the Aryl Hydrocarbon Receptor Activating Environmental Pollutants on Autism Spectrum Disorder Int J Mol Sci. 2021 Aug 26;22(17):. PMID: 34502168", "BibTeX": "@article{34502168, title={Influence of the Aryl Hydrocarbon Receptor Activating Environmental Pollutants on Autism Spectrum Disorder}, author={Dhulkifle H and Agouni A and Zeidan A and Al-Kuwari MS and Parray A and Tolefat M and Korashy HM}, journal={Int J Mol Sci}, volume={22}, number={17}}"}}, {"_id": "32415700", "pmid": 32415700, "title": "Novel potential of metformin on valproic acid-induced autism spectrum disorder in rats: involvement of antioxidant defence system.", "journal": "Fundam Clin Pharmacol", "authors": ["Ishola IO", "Balogun AO", "Adeyemi OO"], "date": "2020-12-01T00:00:00Z", "doi": "10.1111/fcp.12567", "meta_date_publication": "2020 Dec", "meta_volume": "34", "meta_issue": "6", "meta_pages": "650-661", "score": 50254.406, "text_hl": "Hence, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ could be a potential adjunct in the management of @<m>DISEASE_Autism_Spectrum_Disorder</m> @DISEASE_MESH:D000067877 @@@autism spectrum disorders@@@.", "citations": {"NLM": "Ishola IO, Balogun AO, Adeyemi OO. Novel potential of metformin on valproic acid-induced autism spectrum disorder in rats: involvement of antioxidant defence system. Fundam Clin Pharmacol. 2020 Dec;34(6):650-661. PMID: 32415700", "BibTeX": "@article{32415700, title={Novel potential of metformin on valproic acid-induced autism spectrum disorder in rats: involvement of antioxidant defence system.}, author={Ishola IO and Balogun AO and Adeyemi OO}, journal={Fundam Clin Pharmacol}, volume={34}, number={6}, pages={650-661}}"}}, {"_id": "35888087", "pmid": 35888087, "pmcid": "PMC9320776", "title": "Metformin-Treatment Option for Social Impairment? An Open Clinical Trial to Elucidate the Effects of Metformin Treatment on Steroid Hormones and Social Behavior", "journal": "Life (Basel)", "authors": ["Gasser B", "Kurz J", "Buerki S", "Mohaupt M"], "date": "2022-07-05T00:00:00Z", "doi": "10.3390/life12070998", "meta_date_publication": "2022 Jul 5", "meta_volume": "12", "meta_issue": "7", "meta_pages": "", "score": 50253.414, "text_hl": "Changes in social behavior measured by the @<m>DISEASE_Autism_Spectrum_Disorder</m> @DISEASE_MESH:D000067877 @@@Autism-Spectrum@@@ Quotient AQ (see below) prior to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment start and after 12 weeks of treatment.", "citations": {"NLM": "Gasser B, Kurz J, Buerki S, Mohaupt M. Metformin-Treatment Option for Social Impairment? An Open Clinical Trial to Elucidate the Effects of Metformin Treatment on Steroid Hormones and Social Behavior Life (Basel). 2022 Jul 5;12(7):. PMID: 35888087", "BibTeX": "@article{35888087, title={Metformin-Treatment Option for Social Impairment? An Open Clinical Trial to Elucidate the Effects of Metformin Treatment on Steroid Hormones and Social Behavior}, author={Gasser B and Kurz J and Buerki S and Mohaupt M}, journal={Life (Basel)}, volume={12}, number={7}}"}}, {"_id": "35131336", "pmid": 35131336, "title": "Novel role of peroxisome proliferator activated receptor-alpha in valproic acid rat model of autism: Mechanistic study of risperidone and metformin monotherapy versus combination.", "journal": "Prog Neuropsychopharmacol Biol Psychiatry", "authors": ["Elnahas EM", "Abuelezz SA", "Mohamad MI", "Nabil MM", "Abdelraouf SM", "Bahaa N", "Hassan GAM", "Aboul-Fotouh S"], "date": "2022-06-08T00:00:00Z", "doi": "10.1016/j.pnpbp.2022.110522", "meta_date_publication": "2022 Jun 8", "meta_volume": "116", "meta_issue": "", "meta_pages": "110522", "score": 50253.375, "text_hl": "Moreover, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ was able to alleviate the @CHEMICAL_Risperidone @CHEMICAL_MESH:D018967 @@@RIS@@@ induced @DISEASE_Weight_Gain @DISEASE_MESH:D015430 @@@weight gain@@@ and improve cognitive functions highlighting its promising adjunctive role in alleviating @<m>DISEASE_Autism_Spectrum_Disorder</m> @DISEASE_MESH:D000067877 @@@ASD@@@ pathophysiology. ", "citations": {"NLM": "Elnahas EM, Abuelezz SA, Mohamad MI, Nabil MM, Abdelraouf SM, Bahaa N, Hassan GAM, Aboul-Fotouh S. Novel role of peroxisome proliferator activated receptor-alpha in valproic acid rat model of autism: Mechanistic study of risperidone and metformin monotherapy versus combination. Prog Neuropsychopharmacol Biol Psychiatry. 2022 Jun 8;116():110522. PMID: 35131336", "BibTeX": "@article{35131336, title={Novel role of peroxisome proliferator activated receptor-alpha in valproic acid rat model of autism: Mechanistic study of risperidone and metformin monotherapy versus combination.}, author={Elnahas EM and Abuelezz SA and Mohamad MI and Nabil MM and Abdelraouf SM and Bahaa N and Hassan GAM and Aboul-Fotouh S}, journal={Prog Neuropsychopharmacol Biol Psychiatry}, volume={116}, pages={110522}}"}}, {"_id": "39676223", "pmid": 39676223, "title": "Metformin efficacy and safety as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled trial.", "journal": "J Psychopharmacol", "authors": ["Bazrafshan Z", "Mohammadi P", "Hasanzadeh A", "Sanjari Moghaddam M", "Kabiri M", "Sanjari Moghaddam H", "Abdolghaffari AH", "Mohammadi MR", "Akhondzadeh S"], "date": "2024-12-15T00:00:00Z", "doi": "10.1177/02698811241303593", "meta_date_publication": "2024 Dec 15", "meta_volume": "", "meta_issue": "", "meta_pages": "2698811241303593", "score": 50253.27, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ efficacy and safety as an adjunctive treatment for @DISEASE_Mental_Disorders @DISEASE_MESH:D001523 @@@irritability@@@ in children with @<m>DISEASE_Autism_Spectrum_Disorder</m> @DISEASE_MESH:D000067877 @@@autism spectrum disorder@@@: A randomized, double-blind, placebo-controlled trial.", "citations": {"NLM": "Bazrafshan Z, Mohammadi P, Hasanzadeh A, Sanjari Moghaddam M, Kabiri M, Sanjari Moghaddam H, Abdolghaffari AH, Mohammadi MR, Akhondzadeh S. Metformin efficacy and safety as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled trial. J Psychopharmacol. 2024 Dec 15;():2698811241303593. PMID: 39676223", "BibTeX": "@article{39676223, title={Metformin efficacy and safety as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled trial.}, author={Bazrafshan Z and Mohammadi P and Hasanzadeh A and Sanjari Moghaddam M and Kabiri M and Sanjari Moghaddam H and Abdolghaffari AH and Mohammadi MR and Akhondzadeh S}, journal={J Psychopharmacol}, pages={2698811241303593}}"}}, {"_id": "35240246", "pmid": 35240246, "title": "Effect of metformin in autistic BTBR T + Itpr3tf/J mice administered a high-fat diet.", "journal": "Brain Res Bull", "authors": ["Deng W", "Li F", "Ke H", "Wang S", "Li Z", "Lv P", "Chen Y"], "date": "2022-06-01T00:00:00Z", "doi": "10.1016/j.brainresbull.2022.02.021", "meta_date_publication": "2022 Jun 1", "meta_volume": "183", "meta_issue": "", "meta_pages": "172-183", "score": 50248.04, "text_hl": "In this model, we also examined the medication effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@) which is known to ameliorate several symptoms of @<m>DISEASE_Autism_Spectrum_Disorder</m> @DISEASE_MESH:D000067877 @@@autism spectrum disorder@@@ (@<m>DISEASE_Autism_Spectrum_Disorder</m> @DISEASE_MESH:D000067877 @@@ASD@@@). ", "citations": {"NLM": "Deng W, Li F, Ke H, Wang S, Li Z, Lv P, Chen Y. Effect of metformin in autistic BTBR T + Itpr3tf/J mice administered a high-fat diet. Brain Res Bull. 2022 Jun 1;183():172-183. PMID: 35240246", "BibTeX": "@article{35240246, title={Effect of metformin in autistic BTBR T + Itpr3tf/J mice administered a high-fat diet.}, author={Deng W and Li F and Ke H and Wang S and Li Z and Lv P and Chen Y}, journal={Brain Res Bull}, volume={183}, pages={172-183}}"}}]}